Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Krzykalla

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|December 22, 2019
Exploratory identification of predictive biomarkers in randomized trials with normal endpointsJulia Krzykalla, Axel Benner, Annette Kopp-Schneider
BMC Medical Research Methodology|June 27, 2026
Tree-based exploratory identification of predictive biomarkers in non-randomized dataJulia Krzykalla, Maral Saadati, Wiebke Hielscher, et al.
International Journal of Cancer|July 5, 2020
Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: A prospective population-based patient cohort studyAudrey Y Jung, Anika Hüsing, Sabine Behrens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2017
Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid MalignanciesAleksandar Radujkovic, Lambros Kordelas, Julia Krzykalla, et al.
ERJ Open Research|March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosisWim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Oncotarget|October 6, 2017
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trialJonathan P GroΔ, Johanna Nattenmüller, Stefan Hemmer, et al.
Oncoimmunology|January 9, 2018
High numbers of PDCD1 (PD-1)-positive T cells and <i>B2M</i> mutations in microsatellite-unstable colorectal cancerJonas Janikovits, Meike Müller, Julia Krzykalla, et al.
Frontiers in Immunology|April 25, 2022
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort StudyFelix Korell, Olaf Penack, Mike Mattie, et al.
Haematologica|July 13, 2019
Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantationAleksandar Radujkovic, Lambros Kordelas, Julia Krzykalla, et al.
British Journal of Haematology|August 3, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-upMarco Basset, Christoph R Kimmich, Nicholas Schreck, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|December 22, 2019
Exploratory identification of predictive biomarkers in randomized trials with normal endpointsJulia Krzykalla, Axel Benner, Annette Kopp-Schneider
BMC Medical Research Methodology|June 27, 2026
Tree-based exploratory identification of predictive biomarkers in non-randomized dataJulia Krzykalla, Maral Saadati, Wiebke Hielscher, et al.
International Journal of Cancer|July 5, 2020
Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: A prospective population-based patient cohort studyAudrey Y Jung, Anika Hüsing, Sabine Behrens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2017
Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid MalignanciesAleksandar Radujkovic, Lambros Kordelas, Julia Krzykalla, et al.
ERJ Open Research|March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosisWim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Oncotarget|October 6, 2017
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trialJonathan P GroΔ, Johanna Nattenmüller, Stefan Hemmer, et al.
Oncoimmunology|January 9, 2018
High numbers of PDCD1 (PD-1)-positive T cells and <i>B2M</i> mutations in microsatellite-unstable colorectal cancerJonas Janikovits, Meike Müller, Julia Krzykalla, et al.
Frontiers in Immunology|April 25, 2022
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort StudyFelix Korell, Olaf Penack, Mike Mattie, et al.
Haematologica|July 13, 2019
Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantationAleksandar Radujkovic, Lambros Kordelas, Julia Krzykalla, et al.
British Journal of Haematology|August 3, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-upMarco Basset, Christoph R Kimmich, Nicholas Schreck, et al.
Pageof 3